Correlation Between RenovoRx and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Eliem Therapeutics, you can compare the effects of market volatilities on RenovoRx and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Eliem Therapeutics.
Diversification Opportunities for RenovoRx and Eliem Therapeutics
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between RenovoRx and Eliem is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of RenovoRx i.e., RenovoRx and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between RenovoRx and Eliem Therapeutics
Given the investment horizon of 90 days RenovoRx is expected to generate 0.87 times more return on investment than Eliem Therapeutics. However, RenovoRx is 1.15 times less risky than Eliem Therapeutics. It trades about 0.37 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.29 per unit of risk. If you would invest 98.00 in RenovoRx on August 29, 2024 and sell it today you would earn a total of 38.00 from holding RenovoRx or generate 38.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 90.91% |
| Values | Daily Returns |
RenovoRx vs. Eliem Therapeutics
Performance |
| Timeline |
| RenovoRx |
| Eliem Therapeutics |
RenovoRx and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RenovoRx and Eliem Therapeutics
The main advantage of trading using opposite RenovoRx and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| RenovoRx vs. Eliem Therapeutics | RenovoRx vs. Scpharmaceuticals | RenovoRx vs. Milestone Pharmaceuticals | RenovoRx vs. Seres Therapeutics |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |